Technology area: Biotechnology & Pharmaceuticals
3 pending office actions • 2 art units • 2 examiners • 0 of 3 (0%) have an AI response strategy ready
Emplicure AB (Publ) is currently managing 3 pending office actions in the Biotechnology & Pharmaceuticals technology area. These cases are distributed among 2 distinct examiners and 2 distinct art units. This configuration shows that at least one examiner is handling multiple cases for the company. Practitioners should coordinate their responses to ensure consistency across the 2 distinct art units.
MILLER, MAKENNA RYLEIGH is the busiest examiner for the company, with 2 pending office actions. This concentration means that one individual is responsible for the majority of the 3 pending office actions currently active. The variety of 2 distinct art units involved suggests that the technology is split between different primary classifications within biotechnology. With 3 pending office actions and 2 distinct examiners, the company must manage these relationships while adhering to the standards of each assigned division. This structure requires a focused approach to resolve the 3 pending office actions effectively.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (33%) |
| Double-patenting + other | 2 (67%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MILLER, MAKENNA RYLEIGH | 2 | 100.0% | +0.0% |
| COUGHLIN, DANIEL F | 1 | 38.9% | +18.3% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18831626 | Untitled | MILLER, MAKENNA RYLEIGH | — |
| 18852956 | ALKALINE INTRAORAL FORMULATIONS | MILLER, MAKENNA RYLEIGH | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18852986 | ALKALINE INTRAORAL PRODUCTS | COUGHLIN, DANIEL F | — |
| Art Unit | Apps |
|---|---|
| 1611 | 2 |
| 1619 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18831626 | Untitled | MILLER, MAKENNA RYLEIGH | 1611 | §103DP | Final Rejection | — | Pending | Jun 23, 2025 |
| 18852956 | ALKALINE INTRAORAL FORMULATIONS | MILLER, MAKENNA RYLEIGH | 1611 | §103 | Final Rejection | — | Pending | Sep 30, 2024 |
| 18852986 | ALKALINE INTRAORAL PRODUCTS | COUGHLIN, DANIEL F | 1619 | §103§112DP | Non-Final OA | — | Pending | Sep 30, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialEmplicure AB (Publ) has 3 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Makenna Ryleigh Miller has the most, with 2 of Emplicure AB (Publ)'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
